More about

Idiopathic Pulmonary Fibrosis

News
June 29, 2021
2 min read
Save

Pirfenidone did not delay new prescription of concomitant antitussive drugs in IPF

Pirfenidone did not delay new prescription of concomitant antitussive drugs in IPF

In patients with idiopathic pulmonary fibrosis, pirfenidone delayed new-onset respiratory adverse events and antibiotic prescriptions, but did not delay new prescription of concomitant antitussive drugs compared with placebo.

News
June 28, 2021
2 min read
Save

Study does not support low-dose azithromycin to treat chronic cough in IPF

Study does not support low-dose azithromycin to treat chronic cough in IPF

Treatment with low-dose azithromycin for chronic cough in patients with idiopathic pulmonary fibrosis did not significantly improve cough-related quality of life, severity or frequency compared with placebo.

News
June 08, 2021
2 min read
Save

Antimicrobial therapy fails to improve hospitalization, death in adults with IPF

Antimicrobial therapy fails to improve hospitalization, death in adults with IPF

The addition of co-trimoxazole or doxycycline to usual care did not significantly improve time to respiratory hospitalization or death in adults with idiopathic pulmonary fibrosis, according to results of the CleanUP-IPF trial.

News
May 16, 2021
2 min read
Save

Neighborhood-level disadvantage may impact survival, odds of lung transplant in IPF

Neighborhood-level disadvantage may impact survival, odds of lung transplant in IPF

Patients with idiopathic pulmonary fibrosis living in areas with high neighborhood-level disadvantage may have worse survival and lower odds of lung transplantation, researchers reported.

News
May 06, 2021
2 min read
Save

Development of exertional, resting hypoxemia common in patients with IPF

Development of exertional, resting hypoxemia common in patients with IPF

Patients with idiopathic pulmonary fibrosis appear to have higher cumulative incidences of exertional and resting hypoxemia compared with patients with non-IPF fibrotic interstitial lung disease, researchers reported in Chest.

News
May 04, 2021
2 min read
Save

Active and maternal tobacco smoking around birth increase risk for IPF

Active and maternal tobacco smoking around birth increase risk for IPF

Active and passive tobacco smoking around birth was associated with an increase in the risk for idiopathic pulmonary fibrosis, researchers reported in Chest.

News
April 13, 2021
3 min read
Save

Insights on identification, remediation of environmental exposures in patients with ILD

Insights on identification, remediation of environmental exposures in patients with ILD

A review published in Chest highlights the need for a standardized method to identify and categorize patients’ environmental exposures to aid in the diagnosis and prevention of interstitial lung disease progression.

News
March 24, 2021
1 min read
Save

Gastroesophageal reflux disease may contribute to development of lung fibrosis

Gastroesophageal reflux disease may contribute to development of lung fibrosis

In a new study, the odds of having gastroesophageal reflux disease were nearly two times higher in patients with idiopathic pulmonary fibrosis compared with adults without idiopathic pulmonary fibrosis.

News
March 10, 2021
1 min read
Save

Proton pump inhibitors fail to lower mortality, hospitalization in patients with IPF

Proton pump inhibitors fail to lower mortality, hospitalization in patients with IPF

Use of proton pump inhibitors in patients with idiopathic pulmonary fibrosis was not associated with lower mortality or hospitalization incidence, according to results of a large, real-world study.

News
February 01, 2021
2 min read
Save

IPF mortality in US decreased from 2004 to 2017

IPF mortality in US decreased from 2004 to 2017

Age-adjusted mortality rates for idiopathic pulmonary fibrosis decreased from 2004 to 2017 in the United States, according to a new study published in CHEST.

View more